Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL

por Xiang, Jin-Feng, Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Wu, Chun-Tao, Yang, Jing-Xuan, Qi, Zi-Hao, Wang, Ya-Qi, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Li, Min, Yu, Xian-Jun
Publicado 2016

Retraction: Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL

por Xiang, Jin-Feng, Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Wu, Chun-Tao, Yang, Jing-Xuan, Qi, Zi-Hao, Wang, Ya-Qi, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Li, Min, Yu, Xian-Jun
Publicado 2016

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden

por Liu, Liang, Xu, Hua-Xiang, Wang, Wen-Quan, Wu, Chun-Tao, Xiang, Jin-Feng, Liu, Chen, Long, Jiang, Xu, Jin, Fu, De-Liang, Ni, Quan-Xing, Houchen, Courtney W., Postier, Russell G., Li, Min, Yu, Xian-Jun
Publicado 2016